Merck Global Health Innovation Fund, LLC

VC · Whitehouse Station (United States)

VC

Seed

Series A

AI

Cloud/SaaS

Sign up free to access full profile and submit your pitch.

About

Merck Global Health Innovation Fund, LLC is an accelerator and a venture capital arm of Merck & Co. Inc. specializing in direct and fund of fund investments. In direct investments, the firm specializes in seed/startup, early venture and growth equity investments. The firm invests in digital health and data science companies that facilitate and optimize biopharmaceutical operations with the goal of improving patient care. The firm seeks to invest in therapeutic devices; drug discovery and clinical development; manufacturing, supply chain and IT; access to medicine; digital health, healthcare, health care services, vaccines, consumer electronics, home furnishings, homebuilding, household appliances, housewares and specialties, leisure products, textiles, apparel and luxury goods, animal care products sectors. It seeks to invest in companies built around data, but which also touch on security, privacy, analytics and in areas such as diagnostics, precision medicine, clinical decision-support tools and patient engagement. The firm is geography agnostic with a focus on North America and Europe. In early-stage companies, it invests up to $2 million with up to 20% ownership. In areas aligned with business needs, it invests up to $10 million in series B and C companies with up to 20% ownership. When a business is signing multiyear multimillion services contract, it invests growth capital of minimum $10 million with up to 30% ownership. Overall, it invests up to $15 million in companies. Merck Global Health Innovation Fund, LLC was founded in 2010 and is based in Readington Township, New Jersey.

Investment Criteria